Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
3 minute read
  • Cannabis
  • Markets
  • News
  • Psychedelics

MA, FL And OH Psychedelics Scientists And Educators’ Latest Research And Views

By Lara Goldstein
June 8, 9:44 AM
Along with a growing scientific corpus supporting the therapeutic potential of psychedelics, several states and most noticeably Massachusetts are seeing the decriminalization of natural substances via local measures. 

PSYBF

Read More
6 minute read
  • Cannabis
  • Legal
  • Markets
  • News
  • Penny Stocks
  • Psychedelics
  • Small Cap

Psyched: Psychedelic Therapy In The Workplace, UCL’s Brain Imaging Study, COMPASS Trials And More

By Lara Goldstein
December 13, 4:21 PM
Psychedelic Therapy Now Available As Workplace Benefit, Free Month For Laid-Off Tech Workers

CMPS

Read More
2 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Psychedelics & Environmental Protection: Company Seeks Patents To Synthetically Produce Toad Venom

By Lara Goldstein
December 12, 2:56 PM
Psychedelic therapeutics biotech company PsyBio Therapeutics Corp. (OTCQB: PSYBF) has filed three additional U.S.

PSYBF

Read More
1 minute read
  • Cannabis
  • General
  • Health Care
  • Legal
  • Management
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Psychedelics Production Methods Expect Further IP Protection With 4 New Patents

By Lara Goldstein
December 7, 2:02 PM
Biotech company PsyBio Therapeutics Corp. (OTCQB: PSYBF) has filed four new U.S. Patent Cooperation Treaty (PCT) applications aiming to convert five provisional patent applications. 

PSYBF

Read More
4 minute read
  • Cannabis
  • Legal
  • Markets
  • News
  • Psychedelics

Psyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal’s Decrim Project

By Lara Goldstein
December 6, 3:20 PM
Psychedelic Research & Fed Funding By The National Institute Of Mental Health The National Institute of Mental Health (NIMH) named the types of psychedelics studies to which it would grant funds and further guidance for pre-clinical research and studies with young participants.

AWKNF

Read More
2 minute read
  • Cannabis
  • Earnings
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

PsyBio Therapeutics Reports Interim Third Quarter 2022 Financial Results

By Joana Scopel
December 1, 9:24 PM
PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) reported its unaudited interim financial results for the three and nine-month period ended September 30, 2022.

PSYBF

Read More
3 minute read
  • Cannabis
  • Markets
  • Penny Stocks
  • Psychedelics
  • Small Cap

Most, But Not All, Psychedelics Companies Have Sufficient Liquidity

By Viridian Capital Advisors
September 6, 11:25 AM
The Chart represents the liquidity positions of the 21 Psychedelic sector companies in the Viridian Value Tracker database.

AWKNF

Read More
3 minute read
  • Cannabis
  • Global
  • Management
  • Markets
  • News
  • Penny Stocks
  • Psychedelics
  • Retail Sales

DMT Producer PsyBio And Shrooms Grower Red Light Holland Share Their Most Recent Financial Results

By Lara Goldstein
August 29, 4:09 PM
PsyBio Therapeutics (TSXV: PSYB) (OTCQB: PSYBF), a biotech developing medicines based on naturally-occurring psychedelic substances, and mushroom producer Red Light Holland Corp. (OTC Pink: TRUFF) announced the

PSYBF

Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service